Bioxcel Therapeutics's market cap is currently $7.13M. The company's EPS TTM is $-34.429; its P/E ratio is ―; Bioxcel Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-6.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.38M	$ 375.00K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 120.00K	$ 355.00K	$ -297.00K	$ -188.00K	$ -156.00K
Operating Income	$ -171.78M	$ -159.65M	$ -106.94M	$ -82.30M	$ -33.60M
EBITDA	$ -165.42M	$ -157.38M	$ -107.00M	$ -81.98M	$ -32.81M
Net Income	$ -179.05M	$ -171.85M	$ -106.63M	$ -82.01M	$ -32.34M
Balance Sheet
Cash & Short-Term Investments	$ 65.22M	$ 193.72M	$ 232.97M	$ 213.12M	$ 32.43M
Total Assets	$ 73.70M	$ 205.85M	$ 239.44M	$ 219.94M	$ 36.39M
Total Debt	$ 101.38M	$ 94.16M	$ 1.40M	$ 1.64M	$ 1.03M
Net Debt	$ 36.16M	$ -99.57M	$ -231.57M	$ -211.48M	$ -31.40M
Total Liabilities	$ 130.21M	$ 129.08M	$ 17.77M	$ 13.24M	$ 9.50M
Stockholders' Equity	$ -56.51M	$ 76.78M	$ 221.67M	$ 206.70M	$ 26.89M
Cash Flow
Free Cash Flow	$ -155.03M	$ -135.48M	$ -82.60M	$ -66.67M	$ -28.15M
Operating Cash Flow	$ -155.01M	$ -135.34M	$ -82.15M	$ -66.35M	$ -27.28M
Investing Cash Flow	$ -20.00K	$ -139.00K	$ -445.00K	$ -316.00K	$ -870.00K
Financing Cash Flow	$ 26.52M	$ 96.24M	$ 102.45M	$ 247.36M	$ 18.01M

Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

Income Statement >

Bioxcel Therapeutics Debt to Assets

Balance Sheet >

Bioxcel Therapeutics Cash Flow

Cash Flow >

Bioxcel Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing